Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)

NCT01471028 is registered in ClinicalTrials.gov with Vital Therapies, Inc. as lead sponsor.

NCT NCT01471028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01471028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Lead sponsor
Vital Therapies, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
August 31, 2015
Enrollment
203 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

acute alcoholic hepatitis